Iktos
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$22.02M
Company Overview
Iktos operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Grant round in February 2025.
Iktos is a biotechnology company that utilizes artificial intelligence and robotics platforms to accelerate the drug discovery and development process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Industrial Robotics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iktos Comparables
Compare Iktos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Standigm | 88% | |
| PostEra | 87% | |
| TandemAI | 85% |
For institutional investors. Book with your work email.
Iktos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| Series A | Mar 9, 2023 | ||||
| Seed | Jul 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iktos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agoranov | Seed |
| Région Île-de-France | Grant |
| European Innovation Council Fund | Grant |
| M Ventures | Series A |
| Omnes Capital | Series A |
| European Innovation Council (EIC) Accelerator | Grant |
| European Innovation Council Fund | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Multi-year agreement with Servier Group, potentially exceeding €1 billion.
- Feb 20, 2025
Secured $2.61M in grant funding.
For institutional investors. Book with your work email.
Iktos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iktos's valuation, stock price, and market status.
Is Iktos a public or private company?
Iktos is a private company.
What is the current stock price of Iktos?
Iktos is a private company, so its shares have no public market price. Caplight tracks Iktos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iktos worth (valuation)?
Valuation information for Iktos is not publicly available.
Can I buy Iktos stock?
Iktos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iktos's last funding round?
Iktos's most recent funding round was Grant on February 20, 2025.
Who are the main investors in Iktos?
Key investors in Iktos include M Ventures, M Ventures.
Will Iktos IPO soon?
No public IPO plans have been announced for Iktos.
How can I track Iktos secondary market activity?
Caplight tracks bids, offers, and trades in Iktos's shares on secondary markets.